Other News To Note

 Noven Pharmaceuticals Inc., of Miami, a subsidiary of Hisamitsu Pharmaceutical Co. Inc., said it submitted a new drug application seeking to market low-dose mesylate salt of paroxetine for the treatment of vasomotor symptoms associated with menopause.